These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27295037)

  • 1. microRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma Cells.
    Cui Y; Zhao J; Yi L; Jiang Y
    PLoS One; 2016; 11(6):e0156915. PubMed ID: 27295037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-424/503-mediated Rictor upregulation promotes tumor progression.
    Oneyama C; Kito Y; Asai R; Ikeda J; Yoshida T; Okuzaki D; Kokuda R; Kakumoto K; Takayama K; Inoue S; Morii E; Okada M
    PLoS One; 2013; 8(11):e80300. PubMed ID: 24244675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional astroglial Rictor overexpression induces malignant glioma in mice.
    Bashir T; Cloninger C; Artinian N; Anderson L; Bernath A; Holmes B; Benavides-Serrato A; Sabha N; Nishimura RN; Guha A; Gera J
    PLoS One; 2012; 7(10):e47741. PubMed ID: 23077666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTORC2 is required for proliferation and survival of TSC2-null cells.
    Goncharova EA; Goncharov DA; Li H; Pimtong W; Lu S; Khavin I; Krymskaya VP
    Mol Cell Biol; 2011 Jun; 31(12):2484-98. PubMed ID: 21482669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.
    Lee SL; Chou CC; Chuang HC; Hsu EC; Chiu PC; Kulp SK; Byrd JC; Chen CS
    PLoS One; 2013; 8(6):e67149. PubMed ID: 23840605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of Rictor/mTORC2 in cardiomyocyte differentiation of mouse embryonic stem cells
    Zheng B; Wang J; Tang L; Tan C; Zhao Z; Xiao Y; Ge R; Zhu D
    Int J Biol Sci; 2017; 13(1):110-121. PubMed ID: 28123351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 14-3-3 binding to Rictor of mTORC2 for Akt phosphorylation at Ser473 is regulated by selenoprotein W.
    Jeon YH; Park YH; Kwon JH; Lee JH; Kim IY
    Biochim Biophys Acta; 2013 Oct; 1833(10):2135-42. PubMed ID: 23680186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rictor/mTORC2 pathway in oocytes regulates folliculogenesis, and its inactivation causes premature ovarian failure.
    Chen Z; Kang X; Wang L; Dong H; Wang C; Xiong Z; Zhao W; Jia C; Lin J; Zhang W; Yuan W; Zhong M; Du H; Bai X
    J Biol Chem; 2015 Mar; 290(10):6387-96. PubMed ID: 25564616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.
    Artinian N; Cloninger C; Holmes B; Benavides-Serrato A; Bashir T; Gera J
    J Biol Chem; 2015 Aug; 290(32):19387-401. PubMed ID: 25998128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetraspanin 8-rictor-integrin α3 complex is required for glioma cell migration.
    Pan SJ; Zhan SK; Pan YX; Liu W; Bian LG; Sun B; Sun QF
    Int J Mol Sci; 2015 Mar; 16(3):5363-74. PubMed ID: 25761241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rictor, an mTORC2 Protein, Regulates Murine Lymphatic Valve Formation Through the AKT-FOXO1 Signaling.
    Banerjee R; Knauer LA; Iyer D; Barlow SE; Shalaby H; Dehghan R; Scallan JP; Yang Y
    Arterioscler Thromb Vasc Biol; 2024 Sep; 44(9):2004-2023. PubMed ID: 39087350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.
    Hou G; Zhao Q; Zhang M; Fan T; Liu M; Shi X; Ren Y; Wang Y; Zhou J; Lu Z
    Biomed Pharmacother; 2018 Oct; 106():1348-1356. PubMed ID: 30119206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
    Zhang X; Wang X; Xu T; Zhong S; Shen Z
    Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR.
    Micevic G; Muthusamy V; Damsky W; Theodosakis N; Liu X; Meeth K; Wingrove E; Santhanakrishnan M; Bosenberg M
    Cell Rep; 2016 Mar; 14(9):2180-2192. PubMed ID: 26923591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor.
    Masri J; Bernath A; Martin J; Jo OD; Vartanian R; Funk A; Gera J
    Cancer Res; 2007 Dec; 67(24):11712-20. PubMed ID: 18089801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific blockade of Rictor-mTOR association inhibits mTORC2 activity and is cytotoxic in glioblastoma.
    Benavides-Serrato A; Lee J; Holmes B; Landon KA; Bashir T; Jung ME; Lichtenstein A; Gera J
    PLoS One; 2017; 12(4):e0176599. PubMed ID: 28453552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
    Julien LA; Carriere A; Moreau J; Roux PP
    Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
    Koo J; Wu X; Mao Z; Khuri FR; Sun SY
    J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers.
    Morrison Joly M; Hicks DJ; Jones B; Sanchez V; Estrada MV; Young C; Williams M; Rexer BN; Sarbassov dos D; Muller WJ; Brantley-Sieders D; Cook RS
    Cancer Res; 2016 Aug; 76(16):4752-64. PubMed ID: 27197158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-491-3p/mTORC2/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer.
    Zheng G; Jia X; Peng C; Deng Y; Yin J; Zhang Z; Li N; Deng M; Liu X; Liu H; Lu M; Wang C; Gu Y; He Z
    Oncotarget; 2015 Mar; 6(9):6931-43. PubMed ID: 25749387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.